CreditReports.dk
HomeScreen companies

Øresund Pharma ApS Financials, key figures and credit report

CVR number: 39492059 Established 2018 Industry: 46 Wholesale trade
Company contact details
Orient Plads 1, 2150 Nordhavn info@oresundpharma.com www.oresundpharma.com
Gross profit 39 622.1 kDKK FY 2024 +3.6% vs 2023
EBIT 17 635.6 kDKK FY 2024 -19.6% vs 2023
Net debt 919.5 kDKK FY 2024 +109.9% vs 2023
Quick ratio 0.9 FY 2024 -0.6 vs 2023

Company information

Official name
Øresund Pharma ApS
Personnel
20 persons
Established
2018
Company form
Private limited company
Industry

Data sources and methodology

The information about Øresund Pharma ApS combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2024.

Open the 2024 annual report

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About Øresund Pharma ApS

Øresund Pharma ApS (CVR number: 3949205-9) is a company from KØBENHAVN. The company recorded a gross profit of 39.6 mDKK in 2024. The operating profit was 17.6 mDKK, while net earnings were 13.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was 28.9 %, which can be considered excellent and Return on Equity (ROE) was 43.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 47.6 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Øresund Pharma ApS's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2020
2021
2022
2023
2024
Volume
Net sales
Gross profit2 755.007 275.3917 238.1438 259.5539 622.07
EBIT-21.10810.266 118.2521 941.6917 635.55
Net earnings-86.08281.254 302.3816 750.9713 707.32
Shareholders equity total3 109.333 390.047 692.4324 443.4038 150.72
Balance sheet total (assets)23 025.4223 913.1730 950.7142 518.1281 088.60
Net debt5 168.075 700.406 404.65-9 287.03919.50
Profitability
EBIT-%
ROA0.5 %3.5 %22.3 %59.9 %28.9 %
ROE-3.0 %8.7 %77.6 %104.3 %43.8 %
ROI1.4 %9.4 %52.6 %113.8 %55.6 %
Economic value added (EVA)- 221.69134.504 305.8216 400.1312 474.69
Solvency
Equity ratio13.5 %14.2 %24.9 %57.5 %47.6 %
Gearing166.3 %169.4 %83.3 %0.4 %3.9 %
Relative net indebtedness %
Liquidity
Quick ratio0.80.60.91.50.9
Current ratio1.01.01.22.11.6
Cash and cash equivalents2.5543.484.249 390.69557.24
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2024
28.9%
Rating 83/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2024
47.6%
Rating 38/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of Øresund Pharma ApS before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated